Skip to content

The Effect Of Saileya In Patients With Renal Stone.

A Randomized Controlled Clinical Trial To Study The Effect Of Saileya In Mutrashmari With Special Reference To Renal Calculus. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100774
Enrollment
70
Registered
2026-01-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N202- Calculus of kidney with calculus of ureter

Interventions

None listed

Sponsors

Dr Bhagyashri Prakash Sonawane
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient having clinical sign and symptoms of Mutrashmari like dull pain at renal angle, anorexia, haematuria. 2.All patient age of 18 to 60 years group will be selected irrespective gender, occupation, caste and socioeconomic status. 3.Size of stone 8 to 10 mm present in kidney. 4.Patient who will give written consent for treatment.

Exclusion criteria

Exclusion criteria: 1.Patient with medical conditions like DM, HTN, Chronic Hematuria. Carcinoma, Hydronephrosis, Pyelonephritis, Congenital anomalies of kidney. 2.Size of stone above 10 mm. 3.Patient who are suffering from severe systemic disorder like renal failure and infectious disease. 4.PUJ and UVJ calculus if obstructed. 5.If patient with more than 20 RBC in urine

Design outcomes

Primary

MeasureTime frame
1.Reduction in the size of stone evaluate by USG Abdomen and pelvis. 2. Reduction in symptoms like Pain in Renal angle and Burning micturition assessed by VAS (Visual Analog Scale)Timepoint: 1. Assessment - Baseline and 30 Day 2. Follow Up - 0 Day, 15 Day, 30 Day 3. Post Follow up - 35 Day

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Bhagyashri Prakash Sonawane

SMBT Ayurved College and Hospital

drdkumavat@gmail.com9049059799

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026